Search

Author/Creator Sell, Sabine

1. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. Issue 10358 (1st October 2022)

Authors:
Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C; Fluck, Michael; Eigentler, Thomas K; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Roesch, Alexander; Ziemer, Mirj...
Journal:
Lancet
Issue:
Volume 400:Issue 10358(2022)
Page Start:
1117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry. (February 2021)

Authors:
Moritz, Rose K.C.; Gutzmer, Ralf; Zimmer, Lisa; Meier, Friedegund; Ahmed, Misbah S.; Sell, Sabine; Schlaak, Max; Kapp, Florian; Sachse, Michael M.; Haferkamp, Sebastian; Welzel, Julia; Kähler, Katharina C.; Weichenthal, Michael
Journal:
European journal of cancer
Issue:
Volume 144(2021)
Page Start:
382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search